U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07190560) titled 'Against Chikungunya Virus and Neonatal Infection' on Sept. 17.
Brief Summary: The goal of this clinical trial is to learn if administration of plasma, from a whole blood donation from an individual who has declared a Chikungunya infection for less than 6 months , to a newborn, whose mother has a peripartum chikungunya infection, will have an impact on the proportion of newborns surviving without encephalitis/encephalopathy (EE) within the first 5 days of life. Researchers will compare results to an observational study of 30 newborn who couldn't have been propose to participate at the clinical trial, because of delay of diagnosis or...